{"filing":{"accession_number":"0001213900-26-060029","cik":"0001788028","ticker":"JSPRW","company_name":"Jasper Therapeutics, Inc.","form":"8-K","filing_date":"2026-05-21","report_date":null,"primary_document":"ea0291168-8k_jasper.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1788028/000121390026060029/ea0291168-8k_jasper.htm"},"events":[{"id":845,"run_id":727,"accession_number":"0001213900-26-060029","anchor_item_number":"5.02","event_type":"exec_departure","event_domain":"governance","is_material":true,"confidence":0.75,"summary":"Christian Nolet resigned from the Board of Directors effective May 15, 2026. While the filing also mentions the appointment of Svetlana Lucas to the Audit Committee, the principal disclosed action is Nolet's departure from the Board. Board departures are material to investors as they affect governance and oversight. The explicit statement that the resignation is not due to disagreement mitigates some concern but does not eliminate materiality.","company_name":"Jasper Therapeutics, Inc.","ticker":"JSPRW","filing_date":"2026-05-21","items":[{"id":1098,"accession_number":"0001213900-26-060029","item_number":"5.02","item_title":"Departure of Directors or Certain Officers; Election of Directors;","event_type":"exec_departure","event_domain":"governance","is_material":true,"confidence":0.75,"reasoning":"Christian Nolet resigned from the Board of Directors effective May 15, 2026. While the filing also mentions the appointment of Svetlana Lucas to the Audit Committee, the principal disclosed action is Nolet's departure from the Board. Board departures are material to investors as they affect governance and oversight. The explicit statement that the resignation is not due to disagreement mitigates some concern but does not eliminate materiality.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-05-22T02:57:17.444513+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":1098,"accession_number":"0001213900-26-060029","item_number":"5.02","item_title":"Departure of Directors or Certain Officers; Election of Directors;","event_type":"exec_departure","event_domain":"governance","is_material":true,"confidence":0.75,"reasoning":"Christian Nolet resigned from the Board of Directors effective May 15, 2026. While the filing also mentions the appointment of Svetlana Lucas to the Audit Committee, the principal disclosed action is Nolet's departure from the Board. Board departures are material to investors as they affect governance and oversight. The explicit statement that the resignation is not due to disagreement mitigates some concern but does not eliminate materiality.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-05-22T02:57:17.444513+00:00","company_name":"Jasper Therapeutics, Inc.","ticker":"JSPRW","filing_date":"2026-05-21"}]}